Aldeyra Therapeutics (ALDX) Posts Q1 Loss of $1.56/Share

Aldeyra Therapeutics (NASDAQ: ALDX) reported Q2 EPS of ($1.56), $1.03 worse than the analyst estimate of ($0.53).

For earnings history and earnings-related data on Aldeyra Therapeutics (ALDX) click here.

You May Also Be Interested In

• SanDisk and Micron surge as Apple confirms memory price pass-through
• Air France-KLM (AF:FP) (AFLYY) PT Raised to EUR13.50 at UBS
• Pfizer reafffirms 2026 guidance after CFO transition announcement